Loading...
OTCM
CBDS
Market cap4mUSD
Jul 07, Last price  
0.03USD
1D
5.76%
1Q
-18.71%
Jan 2017
-99.47%
IPO
-97.18%
Name

Cannabis Sativa Inc

Chart & Performance

D1W1MN
P/E
P/S
3.49
EPS
Div Yield, %
Shrs. gr., 5y
21.02%
Rev. gr., 5y
18.34%
Revenues
1m
-24.69%
220,000226,631182,160172,771183,337152,3751,0847,15111,61029,168317,985505,7051,159,7372,035,2831,841,5581,558,7521,173,830
Net income
-1m
L+45.66%
10,0002,596-38,192-41,544-15,817-44,109-43,350,914-14,369,732-7,432,859-3,133,376-7,564,084-4,128,346-3,985,994-2,233,548-2,514,501-955,783-1,392,223
CFO
-63k
L-73.21%
50,00012,876-16,465-14,29378-22,010-325,364-408,481-278,464-252,018-964,661-689,87694,648-191,756-245,986-235,559-63,111

Profile

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.
IPO date
Mar 01, 2010
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,174
-24.69%
1,559
-15.36%
Cost of revenue
1,263
2,712
Unusual Expense (Income)
NOPBT
(89)
(1,153)
NOPBT Margin
Operating Taxes
(219)
Tax Rate
NOPAT
(89)
(934)
Net income
(1,392)
45.66%
(956)
-61.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
290
289
Long-term debt
10
49
Deferred revenue
Other long-term liabilities
778
418
Net debt
151
(139)
Cash flow
Cash from operating activities
(63)
(236)
CAPEX
(2)
Cash from investing activities
(10)
(57)
Cash from financing activities
60
196
FCF
184
(1,173)
Balance
Cash
150
477
Long term investments
Excess cash
91
399
Stockholders' equity
(80,635)
(79,267)
Invested Capital
82,460
81,657
ROIC
ROCE
EV
Common stock shares outstanding
54,554
38,068
Price
0.01
-75.00%
0.04
-79.78%
Market cap
491
-64.17%
1,370
-73.71%
EV
2,002
2,522
EBITDA
63
(991)
EV/EBITDA
31.87
Interest
56
31
Interest/NOPBT